- $55.15m
- $55.15m
- $0.03m
Annual cashflow statement for Daxor, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | N-CSR | N-CSR | N-CSR | N-CSR | N-CSR |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 4.75 | 5.18 | 0.281 | 0.536 | 9.17 |
| Non-Cash Items | -7.72 | -5.94 | -3.99 | -0.525 | -8.62 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.217 | -0.009 | 0.053 | 0.014 | 0.021 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -2.76 | -0.769 | -3.66 | 0.026 | 0.571 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.85 | 0.059 | 3.66 | -0.026 | -0.571 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.093 | -0.711 | 0 | 0 | 0 |